Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Beta Bionics, Inc. (BBNX) Guidance & Earnings Results

On 2026-07-29 Beta Bionics, Inc. mixed guidance: "FY2026 total revenue $131-136M (unchanged); PBP channel mix 37-39% (unchanged); gross margin 58.5-59.5% (raised from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BBNXBeta Bionics, Inc.Follow BBNX — free
Medical Devices · Healthcare
—
Price chart with a free account
Market cap
862.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
27 Oct, in 3 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
29 Jul 26MixedFY2026 total revenue $131-136M (unchanged); PBP channel mix 37-39% (unchanged); gross margin 58.5-59.5% (raised from 57.5-59.5%) · full year
21 Apr 26RaisedRevenue guidance raised to $131-136M from $130-135M; gross margin guidance raised to 57.5%-59.5% from 55.5%-57.5% · full year
17 Feb 26RaisedIntroduced FY2026 revenue guidance of $130-135M and gross margin guidance of 55.5%-57.5% · full year
28 Oct 25RaisedRevenue guidance raised to >$96.5M from $88-93M; gross margin to 54-55% from 52-55%; PBP mix to 27-29% from 25-28% · full year
29 Jul 25RaisedFY25 revenue raised to $88-93M from $82-87M; PBP channel mix raised to 25-28% from 22-25%; gross margin raised to 52-55% from 50-53% · full year

Beta Bionics, Inc. — questions

What guidance did Beta Bionics, Inc. give?
On 2026-07-29: "FY2026 total revenue $131-136M (unchanged); PBP channel mix 37-39% (unchanged); gross margin 58.5-59.5% (raised from 57.5-59.5%)"
When does Beta Bionics, Inc. report earnings?
Beta Bionics, Inc.'s next earnings report is expected on 2026-10-27.

Every figure on this page comes from Beta Bionics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.